Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: Multiple sclerosis and primary biliary cirrhosis

Therapeutic Drug Monitoring

Volumn 18, Issue 4, 1996, Pages 435-437

  McMichael, J ^a   Lieberman, R ^b   McCauley, J ^a   Irish, W ^a   Marino, I ^a   Doyle, H ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Autoimmunity; Concentration response; Tacrolimus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; TACROLIMUS;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER MODEL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MONITORING; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ARTIFICIAL INTELLIGENCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, BILIARY; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TACROLIMUS;

EID: 0029810665     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199608000-00021     Document Type: Conference Paper

References (7)

1. Friedman L, Furberg C, DeMets D. Fundamentals of clinical trials. 2nd ed. Chicago: Mosby-Year Book, 1985.
2. Sanathanan LP, Peck CC, Temple R, Lieberman R, Pledger G. Randomization, PK-controlled dosing and titration: an integrated approach for designing clinical trials. Drug Inf J 1991;25:425-31.
3. Venkararamanan R, Jain A, Warty V, et al. Pharmacokinetics of FK506 in transplant patients. Transplant Proc 1991; 23:2736-40.
4. Warty VS, Venkataramanan R, Zendehrough P. Practical aspects of FK506 analysis (Pittsburgh experience). Transplant Proc 1991;23:2730-31.
5. McMichael J, Irish W, McCauley J, et al. Evaluation of a novel "intelligent" dosing system for optimizing FK506 therapy. Transplant Proc 1991;23:2780-2.
6. McMichael J, Lieberman R, Doyle H, et al. An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders. J Clin Pharmacol 1993;33:599-605.
7. McMichael J, Lieberman R, Doyle H, et al. Computer-guided concentration-controlled trials in autoimmune disorders. Ther Drug Monit 1993;15:510-3.